NVO Summary

  1. NYSE
  2. >
  3. NVO
TickerNVO
DescriptionNOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS'B'DKK1
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. It operates through the following segments: Diabetes & Obesity Care, and Biopharmaceuticals. The Diabetes & Obesity Care segment covers products for insulin; GLP-1 and related delivery systems; oral antidiabetic products; and obesity. The Biopharmaceuticals segment offers products for haemophilia; growth hormone therapy; and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.
ExchangeNYSE
TypeStock
SectorHealthcare
Employees43,258
Next Earnings DateOctober 30th, 2020
IV29.299712%
IV Percentile72nd
IV Rank23.14%
IV Skew9.461069
IV Skew Percentile54th
IV Skew SentimentNeutral
Option Volume144
Volume1,175,667
Price$70.74
Previous Close$70.88
52-Week High$73.81
52-Week Low$49.24
50-Day Moving Avg.$68.34
200-Day Moving Avg.$64.13
10-Day Avg. Volume949,258
20-Day Avg. Volume995,346
30-Day Avg. Volume961,777
3-Month Avg. Volume936,363
EPS$15.93
Outstanding Shares1,793,118,830
Float1,792,806,827
Market Capitalization$128,420,159,400
CurrencyUSD
UpdatedOctober 23rd, 2020